IoM drug safety committee meeting
Executive Summary
IoM Committee on the Assessment of the U.S. Drug Safety System will hold its second meeting July 19-20 at the National Academy of Sciences Building in Washington, D.C. The meeting will be open to the public from 3 p.m.-6 p.m. the first day and 1 p.m.-5:30 p.m. the second day. The IoM panel held its first meeting on June 8 (1"The Pink Sheet" June 13, 2005, p. 6)...
You may also be interested in...
IoM Drug Safety Review Should Reach Beyond FDA, Agency’s Woodcock Says
The scope of the Institute of Medicine's assessment of the U.S. drug safety system must extend beyond an evaluation of FDA's capabilities, FDA Acting Deputy Commissioner for Operations Janet Woodcock said June 8
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.